'IHPBA-APHPBA clinical practice guidelines': international Delphi consensus recommendations for gallbladder cancer.


Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921

Informations de publication

Date de publication:
25 Jul 2024
Historique:
received: 25 06 2024
revised: 12 07 2024
accepted: 16 07 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 27 8 2024
Statut: aheadofprint

Résumé

The Delphi consensus study was carried out under the auspices of the International and Asia-Pacific Hepato-Pancreato-Biliary Associations (IHPBA-APHPBA) to develop practice guidelines for management of gallbladder cancer (GBC) globally. GBC experts from 17 countries, spanning 6 continents, participated in a hybrid four-round Delphi consensus development process. The methodology involved email, online consultations, and in-person discussions. Sixty eight clinical questions (CQs) covering various domains related to GBC, were administered to the experts. A consensus recommendation was accepted only when endorsed by more than 75% of the participating experts. Out of the sixty experts invited initially to participate in the consensus process 45 (75%) responded to the invitation. The consensus was achieved in 92.6% (63/68) of the CQs. Consensus covers epidemiological aspects of GBC, early, incidental and advanced GBC management, definitions for radical GBC resections, the extent of liver resection, lymph node dissection, and definitions of borderline resectable and locally advanced GBC. This is the first international Delphi consensus on GBC. These recommendations provide uniform terminology and practical clinical guidelines on the current management of GBC. Unresolved contentious issues like borderline resectable/locally advanced GBC need to be addressed by future clinical studies.

Sections du résumé

BACKGROUND BACKGROUND
The Delphi consensus study was carried out under the auspices of the International and Asia-Pacific Hepato-Pancreato-Biliary Associations (IHPBA-APHPBA) to develop practice guidelines for management of gallbladder cancer (GBC) globally.
METHOD METHODS
GBC experts from 17 countries, spanning 6 continents, participated in a hybrid four-round Delphi consensus development process. The methodology involved email, online consultations, and in-person discussions. Sixty eight clinical questions (CQs) covering various domains related to GBC, were administered to the experts. A consensus recommendation was accepted only when endorsed by more than 75% of the participating experts.
RESULTS RESULTS
Out of the sixty experts invited initially to participate in the consensus process 45 (75%) responded to the invitation. The consensus was achieved in 92.6% (63/68) of the CQs. Consensus covers epidemiological aspects of GBC, early, incidental and advanced GBC management, definitions for radical GBC resections, the extent of liver resection, lymph node dissection, and definitions of borderline resectable and locally advanced GBC.
CONCLUSIONS CONCLUSIONS
This is the first international Delphi consensus on GBC. These recommendations provide uniform terminology and practical clinical guidelines on the current management of GBC. Unresolved contentious issues like borderline resectable/locally advanced GBC need to be addressed by future clinical studies.

Identifiants

pubmed: 39191539
pii: S1365-182X(24)02223-8
doi: 10.1016/j.hpb.2024.07.411
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Auteurs

Jagannath Palepu (J)

Continental Cancer Centre, Continental Hospitals, Hyderabad, India; Dept. of Surgical Oncology Lilavati Hospital & Research Centre and SL Raheja Hospital, Mumbai, India. Electronic address: drjagannath@gmail.com.

Itaru Endo (I)

Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.

Vikram Anil Chaudhari (VA)

GI and HPB Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.

G V S Murthy (GVS)

PRASHO Foundation, Hyderabad, India; London School of Hygiene and Tropical Medicine, London, UK.

Sirshendu Chaudhuri (S)

Indian Institute of Public Health, Hyderbad, India.

Rene Adam (R)

Department of Hepatobiliary Surgery, Cancer and Transplantation, AP-HP Hôpital Paul Brousse / Univ Paris-Saclay, Centre Hépato-Biliaire, Villejuif, France.

Martin Smith (M)

Surgery, University of the Witwatersrand Johannesburg, Johannesburg, South Africa.

Philip R de Reuver (PR)

Department of Surgery, Radboud Medical Center, Nijmegen, Netherlands.

Javier Lendoire (J)

HPB & Liver Transplantation, Instituto de Trasplantes y Alta Complejidad (ITAC), Buenos Aires, Argentina.

Shailesh V Shrikhande (SV)

GI and HPB Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.

Xabier De Aretxabala (X)

Department of Surgery, Hospital Padre Hurtado/Clinica Alemana, Santiago, Chile.

Bhawna Sirohi (B)

Medical Oncology, Vedanta Medical Research foundation (Balco Medical Centre), Raipur, India.

Norihiro Kokudo (N)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan.

Wooil Kwon (W)

Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.

Sujoy Pal (S)

Deptt of GI Surgery and Liver transplantation, All India Institute of Medical Sciences, New Delhi, India.

Chafik Bouzid (C)

HPB and Digestive Oncology Surgery, Dept. of Surgical Oncology, DBK anti cancer center, Mouloud Mammeri University, Tizi Ouzou, Algeria.

Elijah Dixon (E)

Department of Surgery, University of Calgary, Calgary, Canada.

Sudeep Rohit Shah (SR)

GI & HPB Surgery, PD Hinduja Hospital, Mumbai, India.

Rodrigo Maroni (R)

Head of Program of Surgery, Hospital Papa Francisco, Salta, Argentina.

Bruno Nervi (B)

Chief Department, Department of Hematology and Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.

Claudio Mengoa (C)

Surgery, Instituto Regional de Enfermedades Neoplasicas, Arequipa, Peru.

Shekhar Patil (S)

Oncology, HCG, Bangalore, India.

Tomoki Ebata (T)

Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Shishir K Maithel (SK)

Professor of Surgery, Department of Surgery, Emory University, Atlanta, USA.

Hauke Lang (H)

Visceral- and Transplantation Surgery, Universitätsmedizin Mainz, Mainz, Germany.

John Primrose (J)

Department of Surgery, University of Southampton, Southampton, UK.

Satoshi Hirano (S)

Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Oscar A Guevara (OA)

Surgery, Universidad Nacional de Colombia / Instituto Nacional de Cancerologia, Bogota, Colombia.

Masayuki Ohtsuka (M)

Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.

Juan W Valle (JW)

Chief Medical Officer, Research Department, Cholangiocarcinoma Foundation, Herriman, UT, USA.

Atul Sharma (A)

Medical Oncology, Max Institute Of Cancer Care, New Delhi, India.

Ganesh Nagarajan (G)

Surgical oncology ( GI and HPB), Nanavati Max hospital mumbai, Mumbai, India.

Juan Jose Núñez Ju (JJ)

HPB General Surgery Service, Hospital Nacional Guillermo Almenara, Lima, Peru.

Gerardo Francisco Arroyo (GF)

Oncology, CeDIT (Centro de Diagnóstico, Investigación y Tratamiento), Salta, Argentina.

Sergio Lopez Torrez (SL)

Oncology Surgery, Vivian Pellas Hospital, Managua, Nicaragua.

Joris Ivo Erdmann (JI)

Surgery, Cancer Center Amsterdam, Amsterdam, Netherlands.

Jean M Butte (JM)

Surgery, Instituto Oncologico FALP, Santiago, Chile.

Junji Furuse (J)

Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.

Seung Eun Lee (SE)

Department of surgery, Chung-Ang University College of Medicine, Seoul, South Korea.

António Pedro Gomes (AP)

Surgery Department, Hospital Vila Franca de Xira, Vila Franca de Xira, Portugal.

Sang-Jae Park (SJ)

Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang-si, South Korea.

Jin-Young Jang (JY)

Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.

Ricardo Oddi (R)

Center for Clinical Medical Education and Research (CEMIC), Buenos Aires, Argentina.

Savio George Barreto (SG)

HPB and Liver Transplant Unit, Flinders Medical Centre, Flinders University, Austraila.

Hiroshi Kijima (H)

Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.

Oriana Ciacio (O)

Centre Hépato-Biliaire, AP-HP - Hôpital Paul Brousse / Paris-Saclay University, Villejuif, France.

Nagesh S Gowda (NS)

Institute of Gastroenterology and Organ Transplantation, Bengaluru, India.

William Jarnagin (W)

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA.

Classifications MeSH